In pancreatic cancer, the ratio of Tregs to CD4+ T (%Treg) has demonstrated a significant association with shorter survival, while tumor-infiltrating CD4+ Thigh/CD8+ Thigh/%Treglow independently predicted longer overall survival [26]. This evidence concerns the gene CD4 and familial pancreatic carcinoma.